Inosine: Parkinson's Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement. Drug Inosine is proposed to slow progression of this disease. Here is the latest research on Inosine in PD.

September 6, 2020
Preprint
Open Access

MiREDiBase: a manually curated database of editing events in microRNAs

BioRxiv : the Preprint Server for Biology
G. P. MarcecaGiovanni Nigita
September 15, 2020

Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb

Journal of Parkinson's Disease
Aishwarya S KulkarniDaniel W Wesson
September 22, 2020
Preprint

RNA adenosine deaminase ADAR2 modulates T helper 17 cell effector function

BioRxiv : the Preprint Server for Biology
S. MaWendy Jia Men Huang
September 3, 2020
Open Access

Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine

Medicine
Hirohisa WatanabeGen Sobue
September 11, 2020
Open Access

Purine nucleoside phosphorylase Inhibition ameliorates age-associated lower urinary tract dysfunctions

JCI Insight
Lori A BirderEdwin K Jackson
September 15, 2020

Estimation of Cognitive Performance Based on Premorbid Intelligence in Parkinson's Disease

Journal of Parkinson's Disease
Rocio Del PinoNatalia Ojeda
September 15, 2020

Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease

Journal of Parkinson's Disease
Christine L WestWolfgang A Kunze
September 15, 2020
Review

The Universal Prescription for Parkinson's Disease: Exercise

Journal of Parkinson's Disease
Jay L Alberts, Anson B Rosenfeldt
September 10, 2020
Preprint
Open Access

Upgraded adenine base editor (uABE) with minimized RNA off-targeting activity

ResearchSquare
Jianan LiYunbo Qiao
September 10, 2020

TOR mediates the autophagy response to altered nucleotide homeostasis in a ribonuclease mutant

Journal of Experimental Botany
Zakayo KazibweDiane C Bassham
September 15, 2020

Are Happiness and Wellbeing the Same Outcome?

Journal of Parkinson's Disease
Joana Pona-Ferreira, Joaquim J Ferreira
September 18, 2020
Open Access

The CRISPR-Cas9 crATIC HeLa transcriptome: Characterization of a novel cellular model of ATIC deficiency and ZMP accumulation

Molecular Genetics and Metabolism Reports
Randall C MazzarinoGuido N Vacano
September 23, 2020
Open Access

Inosine: novel microbiota-derived immunostimulatory metabolite

Cell Research
Guido Kroemer, Laurence Zitvogel
September 8, 2020

Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson's Disease

Journal of Parkinson's Disease
Christopher G TarolliTanya Simuni
September 3, 2020
Preprint
Open Access

A pilot study of thiamine and folic acid in hemodialysis patients with cognitive impairment

ResearchSquare
Renhua LuLeyi Gu
September 16, 2020

Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors

Bioorganic & Medicinal Chemistry Letters
Seungheon LeeGregory D Cuny
September 17, 2020
Open Access

Effect of estradiol on enzymes of vascular extracellular nucleotide metabolism

Hormones : International Journal of Endocrinology and Metabolism
Areta HebanowskaAlicja Braczko

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/inosine-parkinsons-disease/802045dd-a370-4152-9fdc-c13481caa2f4